CTT Pharmaceutical Holdings, Inc. Stock

Equities

CTTH

US12651E1064

Biotechnology & Medical Research

Market Closed - OTC Markets 09:30:00 2024-04-25 am EDT 5-day change 1st Jan Change
0.04 USD +33.78% Intraday chart for CTT Pharmaceutical Holdings, Inc. -20.16% +42.86%
Sales 2013 - Sales 2014 - Capitalization 9.13M
Net income 2013 - Net income 2014 - EV / Sales 2013 * -
Net Debt 2013 0.02 Net Debt 2014 0.01 EV / Sales 2014 -
P/E ratio 2013 *
-
P/E ratio 2014
35.5 x
Employees -
Yield 2013 *
-
Yield 2014
-
Free-Float 14.68%
More Fundamentals * Assessed data
Dynamic Chart
CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech CI
CTT Pharmaceutical Holdings, Inc. Announces Management Appointments CI
CTT Pharmaceutical Holdings, Inc. Provides Update on the Successful Commercial Introduction of its Sublingual Strips with Aurora Cannabis CI
CTT Pharmaceutical Holdings, Inc. Announces Management Changes CI
Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers CI
Rapid Dose Therapeutics Inc. cancelled the acquisition of certain assets of CTT Pharmaceutical Holdings, Inc.. CI
CTT Pharmaceutical Holdings, Inc. Appoints Jason Dyck to Board of Directors CI
CTT Pharmaceuticals Announces Executive Management Change CI
CTT Pharmaceutical Holdings, Inc. announced that it has received $1 million in funding from Aurora Cannabis Inc. CI
CTT Pharmaceutical Holdings, Inc. announced that it expects to receive $1 million in funding from Aurora Cannabis Inc. CI
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical CI
Rapid Dose Therapeutics Inc. signed a letter of intent to acquire certain assets of CTT Pharmaceutical Holdings, Inc.. CI
CTT Pharmaceutical Holdings and CanniMed Therapeutics Complete Exclusive Canadian Licensing Agreement CI
CanniMed Ltd. Enters into Letter of Intent with CTT Pharmaceutical Holdings Inc. to License CTT's Orally Dissolvable Thin Film Wafer Technology CI
CTT Pharmaceutical Holdings, Inc. Announces Resignation of Lucie Letellier as Chief Financial Officer CI
More news
1 day+33.78%
1 week-20.16%
Current month-20.00%
1 month+25.39%
3 months+2.56%
6 months+100.00%
Current year+42.86%
More quotes
1 week
0.03
Extreme 0.0273
0.04
1 month
0.03
Extreme 0.0272
0.09
Current year
0.01
Extreme 0.01
0.09
1 year
0.00
Extreme 0.003
0.10
3 years
0.00
Extreme 0.003
0.10
5 years
0.00
Extreme 0.003
0.58
10 years
0.00
Extreme 0.003
2.17
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Members of the board TitleAgeSince
Director/Board Member 69 14-09-08
Chief Executive Officer - -
More insiders
Date Price Change Volume
24-04-25 0.04 +33.78% 3,500
24-04-23 0.0299 +9.72% 1,000
24-04-22 0.0272 -31.88% 23,700
24-04-19 0.04 -20.08% 81,654
24-04-18 0.05 +32.41% 10,100

Delayed Quote OTC Markets, April 25, 2024 at 09:30 am EDT

More quotes
CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is specialized in drug delivery systems technology within the pharmaceutical industry. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. Film strip encapsulated with the actives to help in pain reduction can include many combinations to help reduce pain and addiction and help patient safely. Oral Thin strips helps in pain management and inflammation indications, such as Arthritis. The Company has invented an ideal intra oral, fast-dissolving drug delivery system. This novel intraoral drug delivery system is its proprietary patented technology and is a thin, flexible and quick-dissolving film.
More about the company